Acticor Biotech SAS

EPA:ALACT.PA

0.34 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12018 Q22017 Q22016 Q22015 Q22014 Q22013 Q22012 Q2
Revenue 00000000000000000000000
Cost of Revenue 0.72100.00700.0500.03600.04900.05100.05900.0400000000
Gross Profit -0.7210-0.0070-0.050-0.0360-0.0490-0.0510-0.0590-0.0400000000
Gross Profit Ratio 00000000000000000000000
Reseach & Development Expenses 2.1360.00412.1063.5376.8953.4486.2370.0035.1070.0035.6630.0033.8920.0023.3530.0010000000
General & Administrative Expenses 0.0010.0010.0010.9080.0010.7950.0010.0010.0010.0010.0010.00100000000000
Selling & Marketing Expenses 2.01802.860.5392.2560.3432.30302.72101.301000000000000
SG&A 2.0190.0012.8611.4462.2571.1382.3040.0012.7220.0011.3020.0010.8400.86700000000
Other Expenses -0.040-0.02500000000000000000000
Operating Expenses 4.1950.00514.9924.2729.1524.1278.5410.0047.8290.0036.9650.0034.7320.0024.220.0020000000
Operating Income -4.916-0.004-14.999-4.411-9.202-3.926-8.577-0.004-7.878-0.003-7.016-0.003-4.791-0.002-4.26-0.0020000000
Operating Income Ratio 00000000000000000000000
Total Other Income Expenses Net 0.1810-1-0.63-0.481-0.3590.244-00.02-00.33-0-0.047-00.057-00000000
Income Before Tax -4.735-0.004-15.999-5.041-9.683-4.284-8.333-0.004-7.858-0.003-6.686-0.003-4.838-0.002-4.203-0.0020000000
Income Before Tax Ratio 00000000000000000000000
Income Tax Expense 3.8240-5.918-0.038-1.115-0.019-1.0230-1.1560-0.780-0.610-0.7800000000
Net Income -8.559-0.004-10.081-5.041-8.568-4.284-7.31-0.004-6.702-0.003-5.906-0.003-4.228-0.002-3.423-0.0020000000
Net Income Ratio 00000000000000000000000
EPS -0.68-0-0.87-0.44-0.81-0.41-0.69-0-0.64-0-0.56-0-0.4-0-0.32-00000000
EPS Diluted -0.68-0-0.87-0.43-0.81-0.41-0.69-0-0.64-0-0.56-0.38-0.4-0-0.32-00000000
EBITDA -4.195-0.004-14.992-4.407-9.152-3.917-8.541-0.004-7.829-0.003-6.965-0.003-4.732-0.002-4.22-0.0020000000
EBITDA Ratio 00000000000000000000000